SKP2-mediated CDK4 selective degradation contributes to SCP-7e-induced cell death of non-small cell lung cancer
Qiulin Yan, Hui Ren, Haiying Xu, Xuehan Ma, Yuanqing Li, Qiurong Liu, Yi Yang, Qingbo Liu, Guo-Dong Yao, Shao-Jiang Song British Journal of Cancer
· Springer Nature
· 2026-11-07
· DOI: 10.1038/s41416-026-03653-1
Аннотация
British Journal of Cancer, Published online: 07 November 2026; doi:10.1038/s41416-026-03653-1 SKP2-mediated CDK4 selective degradation contributes to SCP-7e-induced cell death of non-small cell lung cancer
Qiulin Yan, Hui Ren, Haiying Xu, Xuehan Ma, Yuanqing Li, Qiurong Liu et al. SKP2-mediated CDK4 selective degradation contributes to SCP-7e-induced cell death of non-small cell lung cancer. // British Journal of Cancer. – 2026. – DOI: 10.1038/s41416-026-03653-1. – URL: https://www.nature.com/articles/s41416-026-03653-1
Qiulin Yan, Hui Ren, Haiying Xu, Xuehan Ma, Yuanqing Li, Qiurong Liu, Yi Yang, Qingbo Liu, Guo-Dong Yao, & Shao-Jiang Song (2026). SKP2-mediated CDK4 selective degradation contributes to SCP-7e-induced cell death of non-small cell lung cancer. British Journal of Cancer. https://doi.org/10.1038/s41416-026-03653-1
Qiulin Yan, et al. “SKP2-mediated CDK4 selective degradation contributes to SCP-7e-induced cell death of non-small cell lung cancer.” British Journal of Cancer, 2026. doi:10.1038/s41416-026-03653-1.
@article{Yan2026,
title = {SKP2-mediated CDK4 selective degradation contributes to SCP-7e-induced cell death of non-small cell lung cancer},
author = {Yan, Qiulin and Ren, Hui and Xu, Haiying and Ma, Xuehan and Li, Yuanqing and Liu, Qiurong and Yang, Yi and Liu, Qingbo and Yao, Guo-Dong and Song, Shao-Jiang},
journal = {British Journal of Cancer},
year = {2026},
doi = {10.1038/s41416-026-03653-1},
url = {https://www.nature.com/articles/s41416-026-03653-1}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment